Acquired hemophilia A manifesting as plasma transfusion-uncontrolled severe bleeding 2 weeks after chorioamnionitis-induced abortion

J Obstet Gynaecol Res. 2017 Apr;43(4):763-767. doi: 10.1111/jog.13270. Epub 2017 Feb 2.

Abstract

Acquired hemophilia A (AHA) is a serious and rare complication of pregnancy, caused by autoantibodies to coagulation factor VIII after delivery. We here report the case of a 36-year-old primigravida woman who developed AHA following chorioamnionitis-caused miscarriage in the second trimester. Thirteen days after abortion, sudden, massive vaginal bleeding occurred with marked prolongation of activated partial thromboplastin time (APTT) in the absence of other abnormal coagulation data. Sequential transfusion of fresh frozen plasma did not achieve normalization of APTT. Further examination confirmed reduction of coagulation factor VIII and the presence of its inhibitor, leading to the final diagnosis of AHA. The patient was effectively treated with bypassing agents (activated prothrombin complex concentrate and recombinant activated factor VII) and immunosuppressive therapy. Fifteen months after remission, the patient became pregnant and successfully achieved term delivery with no signs of recurrence. This case illustrates that AHA should be considered in the occurrence of plasma transfusion-uncontrolled severe bleeding after delivery.

Keywords: acquired hemophilia A; chorioamnionitis; factor VIII inhibitor; plasma transfusion; post-partum hemorrhage.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Induced*
  • Adult
  • Chorioamnionitis*
  • Female
  • Hemophilia A / blood*
  • Hemophilia A / complications
  • Humans
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood*